Nanoform Finland Oyj announced the result of the offering of new shares in an accelerated book building to Nordic and international institutional and other qualified investors. Nanoform expects to receive gross proceeds of approximately EUR 25 million as a result of the Placing. The Placing attracted a considerable number of global and Nordic institutional investors.

The proceeds from the Placing will be used to accelerate Nanoform's growth strategy with an investment in a new manufacturing site in the United States. The new manufacturing site in the USA, the larger pharmaceutical market, is a natural next step for Nanoform, which increases proximity to existing and new customers.